Jumo Health Welcomes Brittany Erana as New CEO
Jumo Health, a frontrunner in enhancing the patient experience within clinical trials, has made significant headlines recently by announcing the appointment of
Brittany Erana as its new
Chief Executive Officer. This strategic decision is anticipated to steer the company into an ambitious growth phase, centering on improving patient activation and decreasing dropout rates during clinical evaluations.
With over two decades of experience in digitally-enabled research and patient-centered innovation, Brittany Erana is well-equipped to assume this pivotal role. Prior to joining Jumo Health, she held the position of
General Manager for patient-first digital solutions at
PPD, a globally recognized contract research organization. Her expertise in implementing digital transformation strategies that enhance the clinical research landscape and improve patient experiences will be crucial for Jumo Health's progressive vision.
Committed to Patient-Centric Healthcare
Expressing her excitement about her new role,
Erana stated, "Building the future of healthcare with the patient at the center has been the throughline of my career. I'm thrilled to be joining Jumo Health at this pivotal moment to help transform how people are engaged in clinical research."
Erana aims to enhance the ways in which patients connect with clinical research from the first touchpoint through to the final visit, ultimately improving the timeline for introducing new therapies to those who need them most. She will collaborate closely with
Falfurrias Management Partners, who acquired Jumo Health in August 2024, to guide the company through its next growth phase.
Addressing Challenges in Clinical Trials
As Jumo Health sets its sights on expanding its capabilities, the focus will be on identifying and tackling key challenges that hinder patient participation in clinical trials. Increasing trial dropout rates, complicated protocols, and extended timelines necessitate a transformation in the way research is approached. According to
Adam Cossman, Jumo Health's Executive Chairman, "Sponsors need more than study awareness campaigns; they require personalized and scalable patient experience solutions."
The need for innovative patient engagement strategies has never been more urgent. With Erana's leadership, Jumo Health is poised to deliver effective solutions that enhance the clarity and accessibility of clinical trials, particularly for underrepresented patient populations.
Jumo Health's Commitment to Innovation
At its core, Jumo Health is dedicated to optimizing patient experiences by integrating behavioral science and creative storytelling to foster informed participation in clinical trials. The company provides resources in 24 therapeutic areas, covering 180 conditions in 90 different languages. It supports 17 of the world’s top 25 life sciences companies in building trust and overcoming the stigma often associated with clinical trials.
By making critical information accessible and engaging, Jumo Health empowers patients to take an active role in their health care decisions, significantly improving their chances of successful clinical trial participation.
The Future of Jumo Health
Looking ahead, the leadership of Brittany Erana is expected to propel Jumo Health into new territories of healthcare innovation. With a keen focus on expanding the company's impact and addressing the barriers patients face, she aims to ensure that both Jumo Health and their clients consistently meet the evolving needs of patients in clinical research. With her at the helm, the future appears bright for Jumo Health as they continue to reshape how clinical trials are conducted and experienced by patients.
This appointment marks a strategic pivot for Jumo Health as it prepares to usher in a new era of patient-centric clinical trials, underscoring its commitment to enhancing the overall healthcare landscape.
For more information about Jumo Health, visit their official website at
www.jumohealth.com.